Cleared Traditional

K152300 - Glucommander

K152300 is the FDA 510(k) clearance for Glucommander by Glytec, LLC. It is a Class 2 General Hospital device (product code NDC) cleared through the Traditional 510(k) pathway after a 721-day FDA review.

K152300 · Glytec, LLC · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2017
Decision
721d
Days
Class 2
Risk

K152300 is an FDA 510(k) clearance for the Glucommander. Classified as Calculator, Drug Dose (product code NDC), Class II - Special Controls.

Submitted by Glytec, LLC (Greenville, US). The FDA issued a Cleared decision on August 4, 2017 after a review of 721 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 868.1890 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General Hospital submissions.

View all Glytec, LLC devices

Submission Details

510(k) Number K152300 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 14, 2015
Decision Date August 04, 2017
Days to Decision 721 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
592d slower than avg
Panel avg: 129d · This submission: 721d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code NDC Calculator, Drug Dose
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - NDC Calculator, Drug Dose

All 25
Devices cleared under the same product code (NDC) and FDA review panel - the closest regulatory comparables to K152300.
EndoTool SubQ
K180366 · Al Pacheco and Associates · Sep 2018
InPen Dose Calculator
K181327 · Companion Medical, Inc. · Jul 2018
Glooko Mobile Insulin Dosing System
K171450 · Glooko, Inc. · Feb 2018
ACCU-CHEK ADVISOR INSULIN GUIDANCE SOFTWARE
K043529 · Roche Diagnostics Corp. · Apr 2005
ABBOTT PHARAMACOKINETICS SYSTEMS
K851573 · Abbott Laboratories · Jan 1986